Press Release
InnoCare Presents Pre-Clinical Data of ICP-723 at AACR Annual Meeting 2022
11 Apr, 2022
97
3727
InnoCare Announces Dosing of First Patient in Clinical Trial of RTK Inhibitor ICP-033 in China
30 Mar, 2022
82
3721
InnoCare to Hold 2022 R&D Day on April 20, 2022
29 Mar, 2022
102
3718
InnoCare Announces Approval of Clinical Trial of TYK2 JH2 Allosteric Inhibitor ICP-488 in China
28 Mar, 2022
117
3703
InnoCare Releases 2021 Annual Results and Business Highlights
23 Mar, 2022
151
3688
InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Waldenström’s Macroglobulinemia in China
14 Mar, 2022
105
3680
InnoCare to Host 2021 Full Year Earnings Call on March 23, 2022
11 Mar, 2022
73
3677
InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of NMOSD in China
02 Mar, 2022
83
3671